Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh K Mishra

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Protein and Peptide Letters|February 9, 2017
Emerging Methods for Structural Analysis of Protein AggregationEshan Khan, Subodh K Mishra, Amit Kumar
Biorxiv : the Preprint Server for Biology|February 13, 2023
Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophySubodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
Molecular Therapy. Nucleic Acids|October 11, 2024
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1Sawyer M Hicks, Jesus A Frias, Subodh K Mishra, et al.
NAR Molecular Medicine|February 19, 2026
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1Subodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
ACS Chemical Biology|February 20, 2026
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease ModelsJesus A Frias, Sawyer M Hicks, Hormoz Mazdiyasni, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Protein and Peptide Letters|February 9, 2017
Emerging Methods for Structural Analysis of Protein AggregationEshan Khan, Subodh K Mishra, Amit Kumar
Biorxiv : the Preprint Server for Biology|February 13, 2023
Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophySubodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
Molecular Therapy. Nucleic Acids|October 11, 2024
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1Sawyer M Hicks, Jesus A Frias, Subodh K Mishra, et al.
NAR Molecular Medicine|February 19, 2026
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1Subodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
ACS Chemical Biology|February 20, 2026
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease ModelsJesus A Frias, Sawyer M Hicks, Hormoz Mazdiyasni, et al.
Pageof 1